Wednesday, November 18, 2015

Pfizer discussing Allergan offer in potential $150B deal

Pfizer is in talks to acquire Allergan for $370-$380 per share, valuing the potential deal at around $150B.

from Mergers and Acquisitions http://ift.tt/1QvgDzg
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)